313 related articles for article (PubMed ID: 22679114)
1. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
Cabrera AR; Cuneo KC; Vredenburgh JJ; Sampson JH; Kirkpatrick JP
J Natl Compr Canc Netw; 2012 Jun; 10(6):695-9. PubMed ID: 22679114
[TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
3. Recent therapeutic advances and insights of recurrent glioblastoma multiforme.
Chen J; Xu T
Front Biosci (Landmark Ed); 2013 Jan; 18(2):676-84. PubMed ID: 23276952
[TBL] [Abstract][Full Text] [Related]
4. Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study.
Park KJ; Kano H; Iyer A; Liu X; Niranjan A; Flickinger JC; Lieberman FS; Lunsford LD; Kondziolka D
J Neurooncol; 2012 Apr; 107(2):323-33. PubMed ID: 22057917
[TBL] [Abstract][Full Text] [Related]
5. Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma.
Morris SL; Zhu P; Rao M; Martir M; Zhu JJ; Hsu S; Ballester LY; Day AL; Tandon N; Kim DH; Shepard S; Blanco A; Esquenazi Y
World Neurosurg; 2019 Jul; 127():e523-e533. PubMed ID: 30954746
[TBL] [Abstract][Full Text] [Related]
6. Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial.
Cabrera AR; Cuneo KC; Desjardins A; Sampson JH; McSherry F; Herndon JE; Peters KB; Allen K; Hoang JK; Chang Z; Craciunescu O; Vredenburgh JJ; Friedman HS; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):873-9. PubMed ID: 23725997
[TBL] [Abstract][Full Text] [Related]
7. Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
Shapiro LQ; Beal K; Goenka A; Karimi S; Iwamoto FM; Yamada Y; Zhang Z; Lassman AB; Abrey LE; Gutin PH
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):636-42. PubMed ID: 22765876
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
Gutin PH; Iwamoto FM; Beal K; Mohile NA; Karimi S; Hou BL; Lymberis S; Yamada Y; Chang J; Abrey LE
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):156-63. PubMed ID: 19167838
[TBL] [Abstract][Full Text] [Related]
9. Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma.
Omar AI
J Vis Exp; 2014 Oct; (92):e51638. PubMed ID: 25407354
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and limitations of stereotactic radiosurgery in the treatment of glioblastoma.
Koga T; Saito N
Neurol Med Chir (Tokyo); 2012; 52(8):548-52. PubMed ID: 22976136
[TBL] [Abstract][Full Text] [Related]
12. Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report.
Lederman G; Arbit E; Odaimi M; Lombardi E; Wrzolek M; Wronski M
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):661-6. PubMed ID: 9486617
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma.
Sheehan JP; Mantziaris G; Bunevicius A
J Neurooncol; 2024 Mar; 167(1):231-232. PubMed ID: 38363492
[No Abstract] [Full Text] [Related]
14. Hypofractionated Radiosurgery Plus Bevacizumab for Locally Recurrent Brain Metastasis with Previously High-Dose Irradiation.
Guan Y; Wang C; Zhu H; Li J; Xu W; Sun L; Pan L; Dai J; Wang Y; Wang E; Wang X
World Neurosurg; 2020 Jan; 133():e252-e258. PubMed ID: 31505283
[TBL] [Abstract][Full Text] [Related]
15. Recurrent malignant gliomas.
Kirkpatrick JP; Sampson JH
Semin Radiat Oncol; 2014 Oct; 24(4):289-98. PubMed ID: 25219814
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel.
Lederman G; Wronski M; Arbit E; Odaimi M; Wertheim S; Lombardi E; Wrzolek M
Am J Clin Oncol; 2000 Apr; 23(2):155-9. PubMed ID: 10776976
[TBL] [Abstract][Full Text] [Related]
17. The added value of bevacizumab concomitantly administered with carboplatin versus carboplatin alone in patients with recurrent glioblastomas.
Kaloshi G; Diamandi P; Cakani B; Brace G; Rroji A; Petrela M
Tumori; 2015; 101(1):41-5. PubMed ID: 25702676
[TBL] [Abstract][Full Text] [Related]
18. Single-agent bevacizumab is an effective treatment in recurrent glioblastoma.
Hacibekiroglu I; Kodaz H; Erdogan B; Turkmen E; Ozcelik M; Esenkaya A; Saygi HM; Uzunoglu S; Cicin I
Med Oncol; 2015 Feb; 32(2):460. PubMed ID: 25572814
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-guided operation in recurrent glioblastoma multiforme treated with bevacizumab-fluorescence of the noncontrast enhancing tumor tissue?
Wachter D; Kallenberg K; Wrede A; Schulz-Schaeffer W; Behm T; Rohde V
J Neurol Surg A Cent Eur Neurosurg; 2012 Nov; 73(6):401-6. PubMed ID: 22777926
[TBL] [Abstract][Full Text] [Related]
20. Recurrent glioblastoma multiforme: potential benefits using fractionated stereotactic radiotherapy and concurrent taxol.
Lederman G; Arbit E; Odaimi M; Wertheim S; Lombardi E
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):162-74. PubMed ID: 9711751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
